{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:22:41Z","timestamp":1789179761308,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007588","name":"Washington State University","doi-asserted-by":"publisher","award":["2021F-ADARP"],"award-info":[{"award-number":["2021F-ADARP"]}],"id":[{"id":"10.13039\/100007588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.dmd.2025.100104","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T11:49:10Z","timestamp":1748260150000},"page":"100104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification of human hepatic UDP-glucuronosyltransferases involved in the glucuronidation of temazepam"],"prefix":"10.1016","volume":"53","author":[{"given":"Keti","family":"Bardhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9652-7591","authenticated-orcid":false,"given":"Mmesoma C.","family":"Anyachebelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmd.2025.100104_bib1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/clpt.1983.85","article-title":"Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives","volume":"33","author":"Abernethy","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100104_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/pharmaceutics16020243","article-title":"Cannabinoid-induced stereoselective inhibition of R-S-oxazepam glucuronidation: cannabinoid\u2013oxazepam drug interactions","volume":"16","author":"Bardhi","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.dmd.2025.100104_bib3","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1021\/acs.molpharmaceut.0c00559","article-title":"Characterization of differential tissue abundance of major non-CYP enzymes in humans","volume":"17","author":"Basit","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.dmd.2025.100104_bib4","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","article-title":"Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man","volume":"269","author":"Bosma","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dmd.2025.100104_bib5","first-page":"104","article-title":"Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases","volume":"400","author":"Court","year":"2005"},{"key":"10.1016\/j.dmd.2025.100104_bib6","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/dmd.30.11.1257","article-title":"Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9","volume":"30","author":"Court","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1124\/dmd.105.009100","article-title":"Importance of UDP-glucuronosyltransferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: decreased glucuronidative activity of the UGT1A10139Lys isoform","volume":"34","author":"Dellinger","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib8","series-title":"StatPearls","article-title":"Temazepam","author":"Fluyau","year":"2024"},{"key":"10.1016\/j.dmd.2025.100104_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/phrs.1993.1011","article-title":"Temazepam: pharmacological profile of a benzodiazepine and new trends in its clinical application","volume":"27","author":"Fraschini","year":"1993","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.dmd.2025.100104_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/dmd.107.018705","article-title":"Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates","volume":"36","author":"Fujiwara","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.dmpk.2014.09.003","article-title":"UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin","volume":"30","author":"Fujiwara","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.dmd.2025.100104_bib12","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J"},{"key":"10.1016\/j.dmd.2025.100104_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00003495-198121050-00001","article-title":"Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic","volume":"21","author":"Heel","year":"1981","journal-title":"Drugs"},{"key":"10.1016\/j.dmd.2025.100104_bib46","series-title":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some Pharmaceutical Drugs","year":"1996"},{"key":"10.1016\/j.dmd.2025.100104_bib14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/jpm11060554","article-title":"The functionality of UDP-glucuronosyltransferase genetic variants and their association with drug responses and human diseases","volume":"11","author":"Jarrar","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.dmd.2025.100104_bib15","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.1038\/srep09627","article-title":"Identifying and applying a highly selective probe to simultaneously determine the O-glucuronidation activity of human UGT1A3 and UGT1A4","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.dmd.2025.100104_bib16","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00204-020-02765-8","article-title":"Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors","volume":"94","author":"Kasteel","year":"2020","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.dmd.2025.100104_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pharmthera.2004.10.013","article-title":"UDP-glucuronosyltransferases and clinical drug\u2013drug interactions","volume":"106","author":"Kiang","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100104_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/toxsci\/kfi211","article-title":"Phenobarbital and phenytoin increased acetaminophen hepatotoxicity due to inhibition of UDP-glucuronosyltransferases in cultured human hepatocytes","volume":"87","author":"Kostrubsky","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.dmd.2025.100104_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/dmd.31.1.133","article-title":"Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6","volume":"31","author":"Krishnaswamy","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1124\/dmd.32.8.862","article-title":"Evaluation of 5-hydroxytryptophol and other endogenous serotonin (5-hydroxytryptamine) analogs as substrates for UDP-glucuronosyltransferase 1A6","volume":"32","author":"Krishnaswamy","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/clpt.1994.137","article-title":"Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus","volume":"56","author":"Lertora","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100104_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/bdd.2510110604","article-title":"Oxidative versus conjugative biotransformation of temazepam","volume":"11","author":"Locniskar","year":"1990","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/bku001","article-title":"Urinary diazepam metabolite distribution in a chronic pain population","volume":"38","author":"Luk","year":"2014","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.dmd.2025.100104_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","article-title":"Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily","volume":"15","author":"Mackenzie","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.dmd.2025.100104_bib25","first-page":"650","article-title":"Temazepam (Restoril, Sandoz Pharmaceuticals)","volume":"16","author":"McElnay","year":"1982","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.dmd.2025.100104_bib26","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/physrev.00058.2017","article-title":"The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms","volume":"99","author":"Meech","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.dmd.2025.100104_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/dmd.119.089482","article-title":"Use of phenotypically poor metabolizer individual donor human liver microsomes to identify selective substrates of UGT2B10","volume":"48","author":"Milani","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1124\/dmd.110.037036","article-title":"Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation","volume":"39","author":"Miners","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108459","article-title":"Drug\u2013drug interactions that alter the exposure of glucuronidated drugs: scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance","volume":"248","author":"Miners","year":"2023","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100104_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107689","article-title":"Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping","volume":"218","author":"Miners","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100104_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.44.101802.121546","article-title":"Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches","volume":"44","author":"Miners","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.dmd.2025.100104_bib32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1124\/dmd.121.000530","article-title":"Inhibition of UDP-glucuronosyltransferase enzymes by major cannabinoids and their metabolites","volume":"49","author":"Nasrin","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.59566\/IJBS.2006.2085","article-title":"Chiral drugs: an overview","volume":"2","author":"Nguyen","year":"2006","journal-title":"Int J Biomed Sci"},{"key":"10.1016\/j.dmd.2025.100104_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00414-010-0418-8","article-title":"An in vitro approach to estimate putative inhibition of buprenorphine and norbuprenorphine glucuronidation","volume":"124","author":"Oechsler","year":"2010","journal-title":"Int J Legal Med"},{"key":"10.1016\/j.dmd.2025.100104_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00008571-199510000-00004","article-title":"Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam","volume":"5","author":"Patel","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.dmd.2025.100104_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00008571-199502000-00005","article-title":"(S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7","volume":"5","author":"Patel","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.dmd.2025.100104_bib37","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1124\/dmd.115.068213","article-title":"Human UDP-glucuronosyltransferase (UGT) 2B10: validation of cotinine as a selective probe substrate, inhibition by UGT enzyme-selective inhibitors and antidepressant and antipsychotic drugs, and structural determinants of enzyme inhibition","volume":"44","author":"Pattanawongsa","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1124\/jpet.110.167916","article-title":"In vitro\u2013in vivo extrapolation predicts drug\u2013drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans","volume":"334","author":"Raungrut","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dmd.2025.100104_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-2797(00)00198-8","article-title":"Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions","volume":"129","author":"Ritter","year":"2000","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.dmd.2025.100104_bib40","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biocel.2013.02.019","article-title":"The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification","volume":"45","author":"Rowland","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.dmd.2025.100104_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0090-9556(25)00105-9","article-title":"Diastereoisomeric glucuronides of oxazepam. Isolation and stereoselective enzymic hydrolysis","volume":"7","author":"Ruelius","year":"1979","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib42","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1021\/acsomega.0c00205","article-title":"Homology modeling of human uridine-5\u2032-diphosphate-glucuronosyltransferase 1A6 reveals insights into factors influencing substrate and cosubstrate binding","volume":"5","author":"Smith","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.dmd.2025.100104_bib43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/FPC.0b013e32833b04af","article-title":"Characterization of 17-dihydroexemestane glucuronidation: potential role of the UGT2B17 deletion in exemestane pharmacogenetics","volume":"20","author":"Sun","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.dmd.2025.100104_bib44","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1124\/dmd.107.017145","article-title":"Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases","volume":"35","author":"Sun","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2710.1999.00247.x","article-title":"Clinically significant pharmacokinetic drug interactions with benzodiazepines","volume":"24","author":"Tanaka","year":"1999","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.dmd.2025.100104_bib47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.105.007369","article-title":"Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) \u201cprobes\u201d for human UDP-glucuronosyltransferases","volume":"34","author":"Uchaipichat","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib48","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1124\/dmd.113.051656","article-title":"The glucuronidation of R- and S-lorazepam: human liver microsomal kinetics, UDP-glucuronosyltransferase enzyme selectivity, and inhibition by drugs","volume":"41","author":"Uchaipichat","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100104_bib49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2125.2006.02588.x","article-title":"Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation","volume":"61","author":"Uchaipichat","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmd.2025.100104_bib51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01974986","article-title":"Direct high pressure liquid chromatographic analysis and preliminary pharmacokinetics of enantiomers of oxazepam and temazepam with their corresponding glucuronide conjugates","volume":"13","author":"Vree","year":"1991","journal-title":"Pharm Weekbl Sci"},{"key":"10.1016\/j.dmd.2025.100104_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.phrs.2017.05.001","article-title":"UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: a systematic review of UGT isoforms for precision medicine","volume":"121","author":"Yang","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.dmd.2025.100104_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1520-636X(1999)11:3<179::AID-CHIR2>3.0.CO;2-G","article-title":"Racemization and stereoselective alcoholysis of temazepam","volume":"11","author":"Yang","year":"1999","journal-title":"Chirality"},{"key":"10.1016\/j.dmd.2025.100104_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0773.1990.tb00737.x","article-title":"Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors","volume":"66","author":"Yue","year":"1990","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.dmd.2025.100104_bib55","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/molecules21081052","article-title":"In vitro inhibition of human UDP-glucuronosyl-transferase (UGT) isoforms by astaxanthin, \u03b2-cryptoxanthin, canthaxanthin, lutein, and zeaxanthin: prediction of in vivo dietary supplement-drug interactions","volume":"21","author":"Zheng","year":"2016","journal-title":"Molecules"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:43:57Z","timestamp":1762231437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625091135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0090955625091135"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100104","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of human hepatic UDP-glucuronosyltransferases involved in the glucuronidation of temazepam","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100104"}}